Abstract
The M2 proton channel from influenza A virus, a prototype for a class of viral ion channels known as viroporins, conducts protons along a chain of water molecules and ionizable side chains, including His37. Recent studies highlight a delicate interplay between protein folding, proton binding and proton conduction through the channel. Drugs inhibit proton conduction by binding to an aqueous cavity adjacent to M2’s proton-selective filter, thereby blocking access of proton to the filter, and altering the energetic landscape of the channel and the energetics of proton-binding to His37.
Introduction
Protein function requires correct folding into a native ensemble of three-dimensional structures with finely orchestrated dynamic interconversion between conformational substates. Thus, protein sequences reflect a compromise between stability and function [1,2]. The thermodynamics of folding have been studied for very few membrane proteins, and the relationships among stability, dynamics, and function remains largely unexplored for this class of proteins [3,4]. Here, we examine these relationships for the M2 proton channel [5] in comparison to the potassium channel KcsA [6–8], focusing on the interplay between folding energetics, permeant ion binding/translocation, and inhibition by binding of pore-blocking drugs.
M2 is a multi-functional, modular protein
The M2 protein, which was discovered as the target of the anti-influenza drugs amantadine and rimantadine [9–11], has multiple functions [5,12,13] associated with different regions of the sequence of this short 97-residue protein. Influenza viruses gain access to cells via receptor-mediated endocytosis, which places the virus within an acidifying endosome. M2 facilitates diffusion of protons into the interior of the endosomally-entrapped virus as the endosome matures, leading to uncoating of the viral RNA from the matrix protein M1 [14]. M2 is also important for delaying acidification of the late Golgi in some strains of the virus [15,16].
M2’s functions are compartmentalized into parsimonious sequences, consisting of:
Residues 1–24 comprise a short unstructured N-terminal region important for incorporation into the virion [17] in influenza A virus, but entirely missing in influenza B virus [18,19].
Residues 25–46 encompass the transmembrane (TM) helix that is necessary and sufficient for tetramerization, proton conductance and drug-binding [20–23]. Drug-resistant mutations map to pore-lining residues of this TM helix (particularly S31N, V27A and L26F) [24–26]. A secondary binding site on the outside of the TM helices is observed when the drug is present at very high concentrations in micelles [27] or bilayers [28], but electrophysiological studies and the drug sensitivities of reverse-engineered viruses showed that this site does not contribute to the pharmacological inhibition of the channel [24–26]. Much work on the structure and function of M2 has been conducted on fragments spanning from residues 22–46, or closely related sequences, which we call M2TM.
Residues 47–61 defines a cytoplasmic amphiphilic helix involved in cholesterol-binding [29], membrane localization, budding and scission [12]. This sequence is not required for channel formation or drug-binding [20,25,29]. Together, the TM and cytoplasmic helices are often studied as a single peptide (approximately residues 20 – 60), defined as M2TM+cyto peptides.
Residues 61–98 comprise a disordered tail that interacts with the matrix protein, M1 [30].
Structure determination of M2’s membrane-interacting domains
The membrane-interactive domains of M2 were identified by limited proteolysis [31], which identified both M2TM+cyto as a meta-stable product, as well as M2TM as a final cleavage product (unpublished result). This, and related studies [20,32,33], showed that the TM domain was both necessary and sufficient to form tetramers and bind amantadine in micelles and bilayers. M2TM has also been the subject of numerous studies using optical spectroscopy (IR [34], Raman [35], CD [32], fluorescence [36], solid state NMR (SSNMR) [23,37–39], X-ray crystallography [40,41], isothermal calorimetry [20], analytical ultracentrifugation [42,43], and surface plasmon resonance [44]) to examine pH activation and drug-binding. Recently, a second series of structural studies focused on the M2TM+cyto fragment, which also includes the cytoplasmic amphiphilic helix [27,45–47].
Before discussing the structural basis for M2’s functions, it is first important to consider the various models and structures proposed for M2 using different techniques, their resolution, and the degree to which the presence or absence of the C-terminal cytoplasmic helix might influence the structure of the pore-forming tetramer. We compare the findings to the potassium channel KcsA [6–8], which has two cytoplasmic domains, consisting of an N-terminal membrane-interactive helix as well as a C-terminal helical bundle domain. Almost all high-resolution structural work on KcsA has been accomplished with constructs lacking its N-terminal and C-terminal cytoplasmic helices. Lower resolution site-directed spin label EPR studies and a 3.8 Å crystal structure [48] showed that the N-terminal cytoplasmic domain formed a helix bound to the membrane surface, while the C-terminal cytoplasmic domain forms a water soluble four-helix bundle [49]. The presence of the C-terminal four-helix bundle has little effect on the channel pore, except to close one end of the bundle slightly more tightly near the activation gate. This is consistent with the fact that the basic structural features, conductance mechanism, and gating mechanism inferred from the structure of KcsA has proven to be general across many mammalian K+ channels. These proteins have very similar channel-forming regions and differ most markedly in their pendant cytoplasmic domains, which help modulate the energetics and kinetics of interconversion of the conformational states underlying gating. Crystallographic structures of the membrane-spanning domains have been invaluable for defining these conformational states, while functional measurements and other lower-resolution methods, such as fluorescence spectroscopy, EPR, solution and solid-state NMR, are indispensable to assign these conformations to discrete functional states and to map their populations and kinetics of interconversion.
The structures of M2TM have been extensively studied by X-ray crystallography and SSNMR. The highest-resolution structure is a 1.65 Å crystal structure [41] of the TM domain (M2TM) from micelles (Figure 1a), which complements earlier crystallographic structures at intermediate resolution (2.0–3.5 Å) [40]. The 1.65 Å-resolution structure precisely pinpoints water molecules and sidechains that form a pathway for proton translocation. Functional water molecules are often very well-ordered, and this structure abounds with waters whose thermal factors are on par with the most ordered backbones. As further discussed below, the most important residues required for proton-channel function are His37 and Trp41, which associate to form a “His-box” and a “Trp-basket” (Fig. 1a). In the crystal structures of M2TM obtained under other conditions [40], the bundle is more splayed at the cytoplasmic end, partially or fully disrupting the His-box.
Figure 1.
Comparison of (a) crystal (PDB: 3LBW), (b) solution NMR (PDB: 2RLF), and (c) solid state NMR (PDB: 2L0J) structures. Backbone is colored in grey, while residues 49–60 are colored in yellow. Critical residues His37 (in cyan) and Trp41 (in green) are key to the extensive hydrogen bond network in the crystal structure. Water clusters are shown in pink.
M2 has been studied by SSNMR in aligned phospholipid mutilayers [50–52] to evaluate the orientation of individual amides via a 15N-based two-dimensional experiment, PISEMA, in which the N-H dipolar coupling and the 15 15N chemical shift anisotropy are correlated [38]. This method defines the crossing angle, kinking and rotation of a monomeric helix relative to the membrane normal. However, many structures of the tetramer can be devised that are consistent with these main-chain restraints, so early SSNMR models of M2TM (2H95, 1NYJ, 2KAD) have now been superceded by more recent, high-resolution crystallographic (3LBW), SSNMR (2KQT, 2L0J) and solution NMR structures (2RLF). Hong and coworkers recently used experimental side chain dihedral restraints and REDOR distance measurements together with the previous dipolar coupling data of Cross and coworkers [51] to obtain a well-defined structure for the M2TM-amantadine complex [28] (2KQT), which is within 1.0 Å r.m.s.d. of the backbone structure of the high-resolution crystallographic structure of M2TM (3LBW) [28].
The M2TM+cyto fragment was recently studied by solution [27,46] and solid-state NMR (SSNMR) [45,47]. The solution structure is at moderate resolution, being defined by 20 inter-monomer NOEs (0.47 per residue), 23 dihedral restraints, and 27 residual dipolar couplings [27] (Figure 1b). The SSNMR structure (2L0J) [47], based on only backbone orientation and membrane depths for the C-terminal helix from EPR studies [53] (Figure 1c), was computed by MD calculations, using these restraints plus reasonable (but nevertheless hypothetical) distance restraints [47]. The solution and SSNMR structures are in reasonable agreement in the TM region; they feature left-crossing transmembrane bundles that place His37 and Trp41 in the pore. However, the cytoplasmic helices differ significantly. In the solution structure [27], it forms a tetrameric bundle extending into the cytoplasm beyond the end of the TM domain (Figure 1b), while the SSNMR structure places the cytoplasmic helix against the C-terminal end of the bundle exposed to the headgroup region of the bilayer [47] (Figure 1c).
One may ask “What is the role of all the detailed interactions formed by the cytoplasmic helices in these structures? Surely, they must be essential for proton channel activity!” To answer this question, the five hydrophobic residues (F47, F48, I51, Y52, F55) in the cytoplasmic helix involved in these interactions were simultaneously changed to Ala in the full-length protein [12,20,29,54]. The surface expression level, proton flux, pH-activation, and drug-binding of this quintuple mutant were indistinguishable from WT, the only change being its inability to promote virus budding and vesicle fission [12,20,29,54]. Thus, the interactions of the cytoplasmic domain in these structures have a subtle effect (if any) on the proton channel activity of the TM domain. They also have little effect on the structure of the TM domain; the overall backbone structures of M2TM are in good agreement with the corresponding TM domains seen in structures of M2TM+cyto constructs, showing small (RMSD 1 to 2 Å) differences within the range associated with subtle changes in bilayer composition [23,55–57]. Thus, studies with the TM construct, which have been conducted in much greater resolution, should provide relevant insight.
The structures of the longer M2TM+cyto constructs help inform the mechanisms of vesicle budding and scission. In a budding virus, M2 localizes to the neck of the budding membrane at a region of extreme curvature that topologically resembles a donut-hole. Such saddle-shaped surfaces have negative Gaussian curvature characterized by orthogonally directed negative and positive local curvature. The cytoplasmic helix is rich in Arg and hydrophobic residues that can promote negative Gaussian curvature [58], and in the SSNMR structure the hydrophobic and positively charged sidechains of the M2 cytoplasmic helix are well positioned to promote negative Gaussian curvature by interacting with phospholipid headgroups. The cytoplasmic helices in the solution NMR structure [27] are less well oriented for this function, but this conformation might serve another functional role. A longer helical bundle is observed in the corresponding BM2 protein from influenza B virus [59]. Also, the C-terminal cytoplasmic helical bundle in KcsA has recently been suggested to dissociate, and its individual helices interact with the membrane during gating [60]. Thus, the full functional role of the M2’s cytoplasmic helix remains a fruitful area for further investigation.
TM structures and dynamics
NMR studies on M2TM and M2TM+cyto have shown that the TM helical motions are strongly modulated by pH, being greatest at acidic pH where the protein functions. The pH-dependent broadening of peaks in the amide region of the solution NMR [27], aligned SSNMR [61], and magic angle spinning SSNMR [62] spectra are indicative of backbone conformational fluctuations in the microsecond to millisecond time scale, and the critical residues His37 and Trp41 also show pH-dependent motions in the microsecond regime [23,27,63]. SSNMR is particularly well suited to examine dynamics of M2TM and M2TM+cyto, because one can access both the slow-exchange to the rapid exchange regimes on the same sample by simply altering the temperature [64]. It also allows exploration of different bilayers to evaluate their effects on dynamics [56,62].
Conformation and dynamics of M2 are also modulated by the chain length of the lipid; short chain lipids tend to increase the crossing angle of the helix relative to the membrane normal [55], allowing a better match between the hydrophobic width of the peptide and the bilayer. Hong and coworkers have used cholesterol-rich bilayers to freeze out rapid uniaxial rotation and minimize contributions from exchange-broadening over a wide range of temperature [56]. The addition of cholesterol is also interesting because it is required for maximal proton channel activity [65,66] and is known to stabilize the tetramer [67]. At ambient temperature, M2TM has two conformations at pH 7.5, and a third conformation at pH 4.5 [62]. The binding of drugs and the composition of the surrounding membrane bilayer also has a large effect on the fraction of each conformational form [62].
The M2TM+cyto construct has also been examined in bilayers by SSNMR. Cross and coworkers used a membrane rich in the non-bilayer-forming phospholipid DOPE (DOPC/DOPE 4:1) to achieve good reconstitution and alignment in multilayers [47]. Two conformations exist in these preparations, based upon doubling of many of the peaks, including S31 (see Figure S3 of the supplementary material from [47]).
The multi-conformational behavior seen in these studies is similar to that seen in parallel solution NMR and SSNMR studies of KcsA, which has multiple structures associated with its gating between resting and conducting states. The opening of the “activation gate” occurs on the low ms time scale [68], and involves large changes in packing of the pore-forming helices, resulting in a 20-Å increase in the diameter of the cytoplasmic section of the pore that leads to the selectivity filter [69]. The structures of the open and closed form of this activation gate, and possible intermediates along the trajectory, have recently been elucidated by X-ray crystallography in KcsA [69], as well as the Na/K channel [70]. The opening motion involves bending and rigid-body tilting of the pore-forming helix (Figure 2a). The use of a minimal construct, lacking the all of the cytoplasmic domains was key to obtaining the full family of conformational states [71]. These truncations removed short segments that, in earlier studies, had engaged in crystallographic packing interactions that otherwise interfered with the marginally stable open activation gate.
Figure 2.

Motions of pore forming helices of KcsA and M2 shown by overlaying KcsA and M2 structures from different sources. a) Ten structures for KcsA (residues 86–122) (PDB codes: 1R3J, 2HVK, 3EFF, 3F5W, 3F7V, 3F7Y, 3FB5, 3FB6, 3FB7, 3FB8). b) Eight structures were analyzed for M2 (residues 25–46) (PDB codes: 2RLF, 3C9J, 2KQT, 2L0J, 3LBW, and three symmetric structures derived from three different helices of the asymmetric structure 3BKD). Figures are adapted from [130].
Figure 2b shows the corresponding ensemble of the TM regions of all recent structures of M2 obtained by X-ray crystallography, solution NMR, and SSNMR. As for KcsA, the structures fall along a smooth trajectory (Figure 2a). The structures are related by a rigid-body tilt of the pore-forming helix with a pivot point near the top of the bundle, causing variable dilation of the C-terminal end of the bundle near His37 and Trp41. A slight (up to 12°) helical bend minimizes the divergence of the helices in the most bent structures. Both motions are supported by SSNMR studies of M2TM in bilayers [23,51]. The concerted nature of the motions suggests movement along a smooth and functionally relevant energy landscape.
There is a general trend towards greater dilation of the C-terminus proximal to His37 under experimental conditions with increased protonation of this residue [40], although the protonation states are not unambiguously defined. Thus, it is reassuring that MD simulations from the groups of Klein [41,71,72] as well as Cross, Zhou and their coworkers [73,74] showed the same trend as the charge state of the four His residues was increased. A small constriction at the N-terminal Val27 valve [40,41,71–73] accompanies the dilation with increased hydration of His37. Thus the weakening of packing at the C-terminus appears to be compensated by improved packing near the N-terminal end of the bundle. The functional significance of this compensatory motion will be discussed below.
The crystal structures lie within various portions of the ensemble (Figure 2b), ranging from the best-packed structure to one in which the helices diverge maximally near the C-terminus. Thus, it is possible that the micelle environment exaggerate the motions that occur in bilayers [57]. However, TM bundles are often not as uniformly well-packed throughout the entire length of a bundle as in water-soluble proteins, so divergence is not necessarily artificial. Gaps in the packing of TM helices are quite frequent, particularly in channels and pores [75], and tend to locate near Trp residues, precisely as found in the M2 structures. Moreover, Cross and coworkers point out that these divergent crystal structures are in good agreement with their own SSNMR data [76], and MD simulations in phospholipid bilayers (see Figure S4 of [47]). Also, while detergents penetrate between the helices near their C-termini in the crystallographic structures, similar gaps are filled by phospholipids or cholesterol in other membrane proteins [77,78]. It is thus interesting to note that cholesterol is required for efficient proton channel activity [65,66]. In summary, these structures show that M2 moves along a smooth trajectory by rigid-body tilting and slight bending near Gly34.
Mechanism of proton conduction through M2
The biochemical mechanism of proton conduction through M2
The mechanism of M2 proton transport has been thoroughly studied in oocytes, mammalian cells, and vesicles [79–81]. The channel has very high proton-selectivity, although protons are at 104 to 106-fold lower concentration than other ions, such as K+, at the pH where M2 functions. M2 has minimal conduction at high pH, because the permeant ion (proton) is at low concentration, and also because protonation of His37 is required to activate the channel for conduction [82]. His37 is required for proton-selectivity, and mutants in which this residue is changed to other side chains form less selective ion channels [83]. M2 is arranged with its N-terminus facing the outside of the virus.
M2 from the highly studied A/Udorn/72 and Weybridge influenza A strains show the interesting property of having greater proton flux when the pH on the N-terminal side of the channel (pHout) is lower than pHin, versus when the gradient is reversed [83,84]. This property requires the presence of Trp, or another electron-rich natural or an unnatural aromatic amino acid sidechain at position 41, one turn down the helix from His37. However, this His-Xxx-Xxx-Xxx-Trp motif alone is insufficient to impart this asymmetric pH-dependence of the conductance. In fact, M2 from the Rostock strain of the virus, whose sequence shares this invariant motif, has just the opposite behavior. M2 from the Rostock stain has greater outward conductance when the pHout is high and pHin is low than the corresponding inward conductance with the reverse gradient [84]. Two single-residue mutations are necessary to switch from Weybridge or (Udorn-like) to a Rostock-like phenotype: N44D and V27I [84]. In structures of Udorn M2 channels, Val27 forms a narrow valve that controls entrance of protons [71,72], while D44 is indirectly hydrogen-bonded to the indole NH of Trp41 via a water cluster at the exit of the channel (Figure 3). D44 is further held in place by a salt bridge to R45 from a neighboring chain [40,41,47]. Thus, D44 and V27 act as gate-keepers at opposite ends of the channel. Mutating Asp44 to Asn might weaken its interactions with Trp41, Arg45, and the exit water cluster, facilitating proton transfer from His37 to the interior of the virus. Indeed, replacing Asp44 with Asn or a variety of other sidechains increases the rate of proton flux through the Weybridge or Udorn M2 proteins [24]. However, the full Rostock phenotype also requires mutation of the other V27 to Ile. This requirement for end-to-end cooperation is reminiscent of the finding of changes occurring throughout the channel when drugs bind to a specific location within the pore [45], as well as the crosstalk between the occupancy of ions in the selectivity filter of KcsA and the opening/closing of the activation gate on the other side of the membrane [69].
Figure 3.

Hydrogen bonding network in the high resolution M2 crystal structure (PDB: 3LBW). Crystal waters are shown in red spheres and named entry cluster, bridging dimer and bridging cluster from Gly/Ala 34 to Asp 44. The histidine residues in the His-box stacks in an edge-to-face conformation and hydrogen bonds to crystallographically well ordered waters in both the entry cluster and bridging dimer. Trp 41 rings are stabilized in a basket-like structure via a third cluster of water molecules-bridging cluster, which bridge the indole NH of Trp41 with the carboxylate of Asp44. This structure is in the + 2 protonation state.
The functional richness of M2’s asymmetric conductance is amplified by a recent conductance study of the full-length protein unidirectionally oriented in phospholipids vesicles in the native topology [65,66]. Building on previous studies [86], robust and reproducible reconstitution required careful consideration of phospholipid composition, particularly the inclusion of cholesterol [66]. This system allowed examination of a question critical to the biological function of M2; how can protons accumulate in the viral interior without developing a large electrical potential that impedes further inward proton translocation? If M2 were perfectly selective for H+ (assuming no other conductance is present), then as protons flow into the virus, a large electrical potential would rapidly ensue, prohibiting inward diffusion of protons before the interior and exterior pH are equilibrated. It proved difficult to address this question electrophysiologically due to the problems of maintaining low inner and outer pH for extended periods [83,84]. Recordings in which the exterior is acidified showed that as the interior became more acidic, the proton flux decreased more than could be accounted for by a change in the chemical potential. Thus, the combination of low interior and exterior pH appeared to diminish selective proton flux. By contrast, manipulation of interior and exterior pH in vesicle systems is much easier, and it was demonstrated that the rate of proton flux was greatest with low pHout and high pHin as in classical experiments [65,66]. However, as the pHin decreases, the proton channel activity of M2 is inhibited. Remarkably, this results in a parallel decrease in its ion selectivity to allow K+ to occasionally flow outward to maintain electrical neutrality. Additionally channel remained proton-selective; note that even a small decrease from the initial selectivity of 106 with the low pHout, high pHin can lead to significant cation flux, because K+ is present at 105-fold higher concentration than protons. This reciprocal inhibition of proton flux and activation of cation flux with decreasing pHin first allows accumulation of protons in the early stages of acidification, then trapping of protons within the virus when low pHin is achieved. Moreover, these findings are in agreement with M2’s recently demonstrated role in activating the inflammasome by disrupting ionic balance in the Golgi [85].
The pH-dependence and magnitude of the proton conductance appears to be optimized to provide the correct degree of proton flux necessary for activity [24] without incurring toxicity to the host cell. Thus, while a large number of mutations to the channel give rise to channels that function in vitro, they have systematically altered conductance characteristics [24]. Only a handful of mutations are functional in viruses that are transmissible between humans, birds, or swine, and these tend to be the same mutations that give channels with properties very similar to WT. Residues that are essentially invariant are G34, H37, W41, and A30 [86]. V27 is occasionally mutated to Ala or Ile, S31 is frequently mutated to Asn, and D44 to Asn [87–91]. The D44N mutation, which increases proton flux 3 to 8-fold, is found in viruses in which it is important to maintain neutrality in the late Golgi [92].
The rate of conduction of protons through M2 shows a sigmoidal dependence on pH, reaching a maximal rate of conductance at low pH [20]. Although the absolute flux rate is slow (reaching 100 to 1000 protons/sec at low pH), the channel operates within an order of magnitude of the diffusion-controlled rate at slightly acidic pH [79]. At subsaturating ion concentrations, the flux rate of ions through a pore generally scales with the ion concentration on the side from which it is diffusing multiplied by a second order rate constant. (Ions can flow in both directions, so a net flux of a given species is observed only in the presence of a TM chemical or electrical gradient) [6]. The rate constant for conduction of protons through an aqueous pore of the approximate dimensions of M2 is about 108 M−1sec−1 [82]. This value is about two orders of magnitude lower than in bulk water, reflecting the restricted dimensions and length of the pore. Thus, at pH 6, the rate of proton conduction would be about 100 sec−1 (108 M−1sec−1 × 10−6 M proton concentration) [82], similar to the value seen at this pH. Thus, near the endosomal pH range over which the channel functions, M2 is a “slow” channel only because of the low concentration of permeant ions. As the pH is lowered, however, the rate does not increase linearly with the proton concentration, but instead levels off at low pH with a midpoint near 6.
Two mechanisms were suggested for the sigmoidal shape of the pH profile. One suggested that protonation of His37 residues leads to opening of the pore [93–97] to allow proton diffusion via chains of hydrogen-bonded “water wires”. However, this mechanism has not been shown to quantitatively account for the full electrophysiological current voltage curves available for M2 or its saturation at low pH [83,84,98,99]. A second, “shuttle” model [79,100,101], instead posits that His residues along the conductance path are protonated and deprotonated as protons pass through the channel. The rate saturates when the conducting His37 residue is fully protonated [83,99], and the rate-limiting-step at low pH becomes deprotonation of His37 (assisted by coordinated motions of Trp41). Interestingly, two of the structural models predicted in the course of developing the shuttle and gated pore models were shown to be highly similar [102], and both were within approximately 1.5 Å r.m.s.d. of the high-resolution crystal structure [41]. Such fine-grained features as the geometry of the His-box and Trp41 basket were correctly predicted in the shuttle model [100].
The pKa values of His37 in the tetramer have been determined by SSNMR [39]: the first two protonations (pKa = 8.2) are surprisingly high, the third pKa = 6.3 matches the midpoint of the conductance curve, and the fourth pKa is ≤ 5 [39]. Thus, the third pKa was found to be the “conducting pKa”, and the shuttling of protons through M2 appears to occur via an alternation of the +2 and +3 states. This situation resembles that in the potassium channels, whose conducting state has a selectivity filter with four K+-binding sites but stably binds only two potassium ions at a time, oscillating between 1–3 and 2–4 configurations with nearly equal occupancy [103–107]. These K+ ions are bound relatively tightly, with a dissociation constant about two orders of magnitude lower than that of the physiological ion concentration [103]. Thus, the binding of the first two ions stabilizes the overall structure and provides a strong driving force to induce a conformation that is selective for binding potassium over sodium ions. Movement of a third K+ into the filter from a site in the aqueous cavity just below the selectivity filter leads to repulsive of an ion into the cellular exterior. Thus, although the structural details are very different, the negative cooperativity between two tight-binding sites and a third weak site provides both high selectivity as well as rapid ion diffusion in both KcsA as well as M2 [108].
Structural mechanism for proton storage and transport through M2
The above observations suggest a potential mechanism for the conduction of M2 that is compatible with the high-resolution structure of the +2 state as well as the structural ensemble seen for the combined structures (Figure 2b). Protons enter the channel through the Val27 valve via transiently populated water molecules via a Grotthuss mechanism [41,73,94,95,97,109–112]. The Val27 gate might constrict in the +3 and +4 states, possibly minimizing loss of a proton to the exterior when His37 reaches the +3 state [71,72].
Once inside the pore, the excess proton passes through an area of disordered solvent and reaches an “entry cluster” (Figure 3) of water molecules that form tight hydrogen bonds with His37, as shown by SSNMR [63]. In the high resolution structure of G34A, four water molecules form a tight simultaneous interaction with His34 and the strongly dipolar carbonyl of residue 34 stabilizing charge in the His-box, and contributing to the strong basicity of the Nδ of His37 [63]. Two additional waters completely associate with the His-bound waters creating an “entry cluster” that bears a striking resemblance to the gas phase structure of hexa-water with a bound excess proton [113]. In the WT structure with Gly at position 34 it is possible that the cluster expands, providing additional opportunities for charge stabilization.
The His residues engage in a His-box interaction (Figure 3) similar to aromatic boxes [114]. There is no direct H-bonding between the imidazoles; instead they are connected via the “entry cluster” and a bridging dimer that cap the top and bottom of the His-box (Figure 3). The water dimer connects the four Nε nitrogens of the His-box, and is well situated to mediate a π-cation interaction to Trp41 basket (Figure 3) [35]. As mentioned above the indole NH of Trp41 interacts with Asp44 via an “exit cluster” of water molecules (Figure 3). Thus, diffusing protons are stabilized by a very extensive network of hydrogen-bonded, π-cation and dipolar interactions, in effect dispersing the effective charge to the outside of the channel.
The basic arrangement of the His-box is also seen in the solution NMR structures [27] as well as a high-resolution SSNMR structure of the amantadine complex [28]. The direct interaction of the His37 Nδ atom with water molecules has been seen at both low and high pH by SSNMR [63]. On the other hand, the water molecule at the Nε of His37 was found to be present only at acidic pH, consistent with a role in stabilizing charge via π-cation interactions.
An alternate orientation of the His residues has, however, been suggested, in which the His37 residues are not hydrogen-bonded to water, but rather to one another in a low-barrier hydrogen bond (LBHB) via an imidazole-imidazolium interaction [39,115]. The hallmarks of this interaction is a close approach of the two heavy atoms, resulting in a low (or no) barrier for transfer of the proton from one atom to another [116]. Because of the ultra-rapid exchange of the proton, the two heavy atoms engaged in the hydrogen bond give rise to a single resonance roughly midway between chemical shift in imidazole-imidazolium pairs generally seen for the donor and acceptor in the 15N NMR spectrum at 270 K and above [115]. At lower temperatures, two peaks of equal intensity can be observed for dimers that deviate from true symmetry, although the exchange in the dimers is rapid throughout the temperature range [115]. The His37 residues of M2TM have also been proposed to form a direct LBHB in the +2 state, although the interpretation was ambiguous due to exchange broadening, which obscured key diagnostic peaks [39]. The chemical shifts assigned to imidazole-imidazolium interactions in this study might instead arise from interactions between His37 and water molecules [63]. Moreover, exchange broadening is generally indicative of microsecond to millisecond processes with significantly larger energetic barriers than that associated with a LBHB, so its presence is not good evidence for a LBHB. A second argument for a LBHB came from quantum mechanical (QM) calculations in which the imidazoles were found to form stable pairwise interactions [47]. This computed geometry was used to guide the MD simulation of the aligned SSNMR structure of M2TM+cyto [47]. However, when water was included in more extensive QM simulations [41,109], the imidazoles were instead found to interact via bridging water molecules, as in the crystal structure. The chemical shifts computed from the crystal structure (supporting information of [41]) are also in agreement with the same aligned SSNMR data [47]. Thus, the His-box is clearly formed in at least one conformational form of the channel. It remains possible that there is a direct interaction of imidazoles in some alternate conformers, but direct evidence for this interaction is not definative. Clearly, the viral membrane mimetic bilayer, with its lack of exchange broadening from axial rotational motions, is well suited for future investigations of this issue [56].
In summary, the recently published high-resolution structure of M2TM, together with many other biochemical and SSNMR studies of M2TM and M2TM+cyto in bilayers, explains how protons enter and are stabilized in the channel, and provides a rationale for the high stability of the +2 state. Furthermore, upon reaching the third protonation state, the highly ordered structure of the His-box is destabilized [63], and the structure of the protein becomes more dynamic, allowing efflux of a proton past Trp41 and into the interior. The mechanism of this final step remains an important challenge. SSNMR [117] and IR spectroscopy [34] studies show an increase in hydration in the +3 state, consistent with the structural and MD studies showing dilation of the C-terminal end of the bundle [71]. Raman spectroscopy [118] shows a protonated His-Trp interaction which forms with a pKa near 6, and presumably reflects residual tertiary interactions retained in the time-averaged structure of the +3 state.
Another challenge will be to refine the original shuttle mechanism which suggested protonation and deprotonation at the Nδ and Nε of the imidazole occured by either a water-mediated tautomerization or a ring-flip as recently proposed in greater detail in [63].
Thermodynamic coupling between the free energy of tetramer assembly, proton-binding, conduction, and drug-binding
M2 is a finely tuned machine, with multiple conformational states whose stability and kinetics of interconversion are tightly controlled by pH. Thus, its sequence has evolved to mediate these processes, rather than to simply form a stable static tetramer [2]. Indeed, mutation of each of M2’s pore-lining or interfacial positions to either Ala or Phe either had no effect on or enhanced the free energy of tetramerization of M2TM [43]. The only exceptions were at a single position in the pore where substitution with Phe was not sterically feasible, or at the polar residue His37, where mutation to Ala or Phe was strongly destabilizing. Thus, the primary determinant for the strong conservation of sequence in M2 reflects the need to maintain the energetic and kinetic balance between its multiple conformational sub-states. To assess how mutations affect a more restricted set of specific conformations of the tetramer, the binding of amantadine to the channel was measured to a set of variants in which the substitution was not located directly within the binding site [43]. In micelles and bilayers, all of the mutations destabilized amantadine binding or were isoenergetic.
The pKas of His37 in the tetramer are strongly perturbed, so pH should control the stability of the tetramer in a biphasic manner. The pKas of the first two protonations of the tetramer (8) are greater than that of the corresponding monomer (app. 6.5), so in the pH range of about 8 to 6.5 the stability of the tetramer should gradually increase with decreasing pH. On the other hand, because the pKa values for the third and fourth protonations of the tetramer are lower than that of the monomer, stability should gradually decrease with decreasing pH below 6. Overall, the equilibrium constant for dissociation of the tetramer (Kobs) at a given pH is:
where Ktet is the dissociation constant for the neutral tetramer, Kmon is the dissociation constant for the protonated monomer, and K1 through K4 are the dissociation constants of the mono, di, tri and tetra protonated His37 in the tetramer.
Analytical ultracentrifugation showed the expected maximum in stability near pH 6.5 for both M2TM and full length M2 [20], confirming the high pKa values for the first two protonations of His37 and helping to define conditions under which the protein could be studied while retaining the tetrameric form. Ion-specific stabilization of the tetrameric form has also been observed for KcsA [119].
The binding of drugs specifically stabilizes the tetrameric form of M2, as expected from thermodynamic linkage. The structure of the physiologically relevant M2-drug complex [28,40] shows many parallels with the complex of KcsA with quarternary ammonium blockers. In both cases, the drugs are bound in an aqueous pocket, blocking access to the selectivity filter or His-box, and also affecting the thermodynamics and kinetics of conformational transitions. As discussed above, binding disrupts the energetic balance of distinct structural state, and also perturbs the pKa of His37 [120].
Recent structure-activity studies have elucidated the interactions required for high-affinity binding [121], and enabled the design of novel inhibitors that are beginning to address the problem of amantadine-resistance [122]. Because the binding site lies along the four-fold symmetry axis of the channel, a single mutation changes four positions per tetramer, which can have a large effect on not only the ability to bind drugs but also the function of the channel [24]. Thus, only a few amantadine-resistant mutations, namely V27A, L26F, and S31N, have been observed in transmissible viruses in the past eight decades for which a genetic record is available [86,123], although other mutations can easily be observed in vitro. The mutations that cause the greatest decrease in inhibition, S31N and V27A, increase the polarity of pore-lining residues.
Computational investigations of amantadine/rimantadine action have involved molecular dynamics (MD) simulations [72,74,95,124], docking [125,126] and small molecule probe mapping [127,128]. Since these studies used various M2 structures/models in varying protonation states, it is not surprising that a consensus failed to emerge from these studies. Using MD, Yi et al found the aliphatic region of amantadine snuggled against the bottom of the Val 27 gate [74], while the drug was found at more C-terminal locations in other simulations [95,129]. Khurana et al [72] performed MD simulations of different protonation states of His37, using crystallographic and solution NMR structures as starting conformations. They found two distinct orientations of the drug in the pore, whose populations depended on the protonation states of His37. These orientations might correspond to the major and minor conformers of amantadine within the pore observed by SSNMR [28].
Figure 4 shows the predominant orientation of the drug [28] docked onto the 1.65 Å high-resolution structure [41]. The ammonium group projects downward towards the entry cluster of water molecules, mimicking a hydronium ion in the act of passing a proton from the central cavity to the His-box. While some rearrangement of the outermost water molecules in the cluster is required to accommodate the more extended drug, rimantadine, the four water molecules associated with the His37 residues appear well positioned to bridge between the sidechain imidazole and the drug ammonium groups. This mode of binding is also consistent with the high affinity of the recently described spiro-piperidine class of inhibitors [121], and has proved to be an excellent model for design of molecules that bind to the mutants V27A and L26F [122].
Figure 4.

Docked conformation of four M2 inhibitors with M2 model generated from the high resolution X-ray crystal structure of M2 (PDB: 3LBW) and SSNMR structure of amantadine bound M2 (PDB: 2KQT). Poses are shown with the amine pointing downwards towards His 37. a) Amantadine b) Rimantadine c) Spiro-piperidine d) Spiran amine. e) The structure of tetrabutylammonium (TBA) bound to KcsA (PDB: 2HVK). Note TBA displaces the K+ hydrate near the entry of the selectivity filter, in a binding manner highly similar to the binding of M2 inhibitors (a–d) to M2, which lie proximal to or displace the top two waters in the entry cluster.
Conclusion
Recent years have seen breakthroughs in the structural biology of M2, which in turn facilitate the mechanistic analysis of proton translocation. High-resolution structures and dynamic measurements of M2 and mutants under different conditions (pH, lipid compositions etc) are needed to fully elucidate the mechanism. Mutant structures are critical for understanding drug-resistance and providing a basis for drug design. On the other hand, inhibitors developed either through design or screening can facilitate structure determination by stabilizing the M2 tetramer in specific conformational forms.
Acknowledgments
This work was funded by the NIH (GM56423 and AI74571). The authors would like to thank Gevorg Grigoryan and Nate Joh for valuable comments and help with preparing the figures.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References and recommended reading
- 1.DePristo MA, Weinreich DM, Hartl DL. Missense meanderings in sequence space: A biophysical view of protein evolution. Nat Rev Genet. 2005;6:678–687. doi: 10.1038/nrg1672. [DOI] [PubMed] [Google Scholar]
- 2.Soichet BK, Baase WA, Kuroki R, Matthews BW. A relationship between protein stability and protein function. Proc Natl Acad Sci U S A. 1995;92:452–456. doi: 10.1073/pnas.92.2.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bowie JU. Solving the membrane protein folding problem. Nature. 2005;438:581–589. doi: 10.1038/nature04395. [DOI] [PubMed] [Google Scholar]
- 4.Stanley AM, Fleming KG. The process of folding proteins into membranes: Challenges and progress. Arch Biochem Biophys. 2008;469:46–66. doi: 10.1016/j.abb.2007.09.024. [DOI] [PubMed] [Google Scholar]
- 5.Pinto LH, Lamb RA. Influenza virus proton channels. Photochem Photobiol Sci. 2006;5:629–632. doi: 10.1039/b517734k. [DOI] [PubMed] [Google Scholar]
- 6.Hille B. Ionic Channels of Excitable Membranes. Sunderland, MA: Sinauer Associates; 1992. [Google Scholar]
- 7.Gouaux E, Mackinnon R. Principles of selective ion transport in channels and pumps. Science. 2005;310:1461–1465. doi: 10.1126/science.1113666. [DOI] [PubMed] [Google Scholar]
- 8.Choe S. Potassium channel structures. Nat Rev Neurosci. 2002;3:115–121. doi: 10.1038/nrn727. [DOI] [PubMed] [Google Scholar]
- 9.Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985;4:3021–3024. doi: 10.1002/j.1460-2075.1985.tb04038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein has ion channel activity. Cell. 1992;69:517–528. doi: 10.1016/0092-8674(92)90452-i. [DOI] [PubMed] [Google Scholar]
- 11.Davies WL, Hoffmann CE, Paulshock M, Wood TR, Haff RF, Grunert RR, Watts JC, Hermann EC, Neumayer EM, McGahen JW. Antiviral activity of 1-adamantanamine (amantadine) Science. 1964;144:862–863. doi: 10.1126/science.144.3620.862. [DOI] [PubMed] [Google Scholar]
- 12.Rossman JS, Jing X, Leser GP, Lamb RA. Influenza Virus M2 Protein Mediates ESCRT-Independent Membrane Scission. Cell. 2010;142:902–913. doi: 10.1016/j.cell.2010.08.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Gannage M, Dormann D, Albrecht R, Dengjel J, Torossi T, Ramer PC, Lee M, Strowig T, Arrey F, Conenello G, et al. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe. 2009;6:367–380. doi: 10.1016/j.chom.2009.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Helenius A. Unpacking the incoming influenza virus. Cell. 1992;69:577–578. doi: 10.1016/0092-8674(92)90219-3. [DOI] [PubMed] [Google Scholar]
- 15.Grambas S, Hay AJ. Maturation of influenza a virus hemagglutinin--Estimates of the pH encountered during transport and its regulation by the M2 protein. Virology. 1992;190:11–18. doi: 10.1016/0042-6822(92)91187-y. [DOI] [PubMed] [Google Scholar]
- 16.Sakaguchi T, Leser GP, Lamb RA. The ion channel activity of the influenza virus M(2) protein affects transport through the Golgi apparatus. J Cell Biol. 1996;133:733–747. doi: 10.1083/jcb.133.4.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Park EK, Castrucci MR, Portner A, Kawaoka Y. The M2 ectodomain is important for its incorporation into influenza A virions. J Virol. 1998;72:2449–2455. doi: 10.1128/jvi.72.3.2449-2455.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Williams MA, Lamb RA. Determination of the Orientation of an Integral Membrane Protein and Sites of Glycosylation by Oligonucleotide-Directed Mutagenesis: Influenza B Virus NB Glycoprotein Lacks a Cleavable Signal Sequence and Has an Extracellular NH2-Terminal Region. Mol Cell Biol. 1986;6:4317–4328. doi: 10.1128/mcb.6.12.4317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sunstrom NA, Premkumar LS, AP, Ewart G, Cox GB, Gage PW. Ion Channels Formed by NB, an Influenza B Virus Protein. J Membr Biol. 1996;150:127–132. doi: 10.1007/s002329900037. [DOI] [PubMed] [Google Scholar]
- 20.Ma C, Polishchuk AL, Ohigashi Y, Stouffer AL, Schon A, Magavern E, Jing X, Lear JD, Freire E, Lamb RA, et al. Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel. Proc Natl Acad Sci U S A. 2009;106:12283–12288. doi: 10.1073/pnas.0905726106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kochendoerfer GG, Salom D, Lear JD, Wilk-Orescan R, Kent SB, DeGrado WF. Total chemical synthesis of the integral membrane protein influenza A virus M2: role of its C-terminal domain in tetramer assembly. Biochemistry. 1999;38:11905–11913. doi: 10.1021/bi990720m. [DOI] [PubMed] [Google Scholar]
- 22.Salom D, Hill BR, Lear JD, DeGrado WF. pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus. Biochemistry. 2000;39:14160–14170. doi: 10.1021/bi001799u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cady SD, Luo W, Hu F, Hong M. Structure and function of the influenza A M2 proton channel. Biochemistry. 2009;48:7356–7364. doi: 10.1021/bi9008837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Balannik V, Carnevale V, Fiorin G, Levine BG, Lamb RA, Klein ML, DeGrado WF, Pinto LH. Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel. Biochemistry. 2010;49:696–708. doi: 10.1021/bi901799k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Jing X, Ma C, Ohigashi Y, Oliveira FA, Jardetzky TS, Pinto LH, Lamb RA. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Proc Natl Acad Sci U S A. 2008;105:10967–10972. doi: 10.1073/pnas.0804958105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ohigashi Y, Ma C, Jing X, Balannick V, Pinto LH, Lamb RA. An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition. Proc Natl Acad Sci U S A. 2009;106:18775–18779. doi: 10.1073/pnas.0910584106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Schnell JR, Chou JJ. Structure and mechanism of the M2 proton channel of influenza A virus. Nature. 2008;451:591–595. doi: 10.1038/nature06531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cady SD, Schmidt-Rohr K, Wang J, Soto CS, DeGrado WF, Hong M. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature. 2010;463:689–692. doi: 10.1038/nature08722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rossman JS, Jing X, Leser GP, Balannik V, Pinto LH, Lamb RA. Influenza Virus M2 Ion Channel Protein is Necessary for Filamentous Virion Formation. J Virol. 2010;84:5078–5088. doi: 10.1128/JVI.00119-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Martin K, Heleniust A. Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell. 1991;67:117–130. doi: 10.1016/0092-8674(91)90576-k. [DOI] [PubMed] [Google Scholar]
- 31.Kochendoerfer GG, Salom D, Lear JD, Wilk-Orescan R, Kent SBH, DeGrado WF. Total chemical synthesis of the integral membrane protein influenza A virus M2: Role of its C-terminal domain in tetramer assembly. Biochemistry. 1999;38:11905–11913. doi: 10.1021/bi990720m. [DOI] [PubMed] [Google Scholar]
- 32.Salom D, Hill BR, Lear JD, DeGrado WF. pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus. Biochemistry. 2000;39:14160–14170. doi: 10.1021/bi001799u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Duff KC, Ashley RH. The Transmembrane Domain of Influenza A M2 Protein Forms Amantadine-Sensitive Proton Channels in Planar Lipid Bilayers. Virology. 1992;190:485–489. doi: 10.1016/0042-6822(92)91239-q. [DOI] [PubMed] [Google Scholar]
- 34.Manor J, Mukherjee P, Lin YS, Leonov H, Skinner JL, Zanni MT, Arkin IT. Gating Mechanism of the Influenza A M2 Channel Revealed by 1D and 2D IR Spectroscopies. Structure. 2009;17:247–254. doi: 10.1016/j.str.2008.12.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Okada A, Miura T, Takeuchi H. Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza A virus. Biochemistry. 2001;40:6053–6060. doi: 10.1021/bi0028441. [DOI] [PubMed] [Google Scholar]
- 36.Czabotar PE, Martin SR, Hay AJ. Studies of structural changes in the M2 proton channel of influenza A virus by tryptophan fluorescence. Virus Res. 2004;99:57–61. doi: 10.1016/j.virusres.2003.10.004. [DOI] [PubMed] [Google Scholar]
- 37.Cady SD, Mishanina TV, Hong M. Structure of amantadine-bound M2 transmembrane peptide of influenza A in lipid bilayers from magic-angle-spinning solid-state NMR: the role of Ser31 in amantadine binding. J Mol Biol. 2009;385:1127–1141. doi: 10.1016/j.jmb.2008.11.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Song Z, Kovacs FA, Wang J, Denny JK, Shekar SC, Quine JR, Cross TA. Transmembrane domain of M2 protein from influenza A virus studied by solid-state (15)N polarization inversion spin exchange at magic angle NMR. Biophys J. 2000;79:767–775. doi: 10.1016/S0006-3495(00)76334-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hu J, Fu R, Nishimura K, Zhang L, Zhou HX, Busath DD, Vijayvergiya V, Cross TA. Histidines, heart of the hydrogen ion channel from influenza A virus: Toward an understanding of conductance and proton selectivity. Proc Natl Acad Sci U S A. 2006;103:6865–6870. doi: 10.1073/pnas.0601944103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Stouffer AL, Acharya R, Salom D, Levine AS, Di Costanzo L, Soto CS, Tereshko V, Nanda V, Stayrook S, DeGrado WF. Structural basis for the function and inhibition of an influenza virus proton channel. Nature. 2008;451:596–599. doi: 10.1038/nature06528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Acharya R, Carnevale V, Fiorin G, Levine BG, Polishchuk AL, Balannik V, Samish I, Lamb RA, Pinto LH, DeGrado WF, et al. Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc Natl Acad Sci U S A. 2010;107:15075–15080. doi: 10.1073/pnas.1007071107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Stouffer AL, Ma C, Cristian L, Ohigashi Y, Lamb RA, Lear JD, Pinto LH, DeGrado WF. The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus. Structure. 2008;16:1067–1076. doi: 10.1016/j.str.2008.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Stouffer AL, Nanda V, Lear JD, DeGrado WF. Sequence determinants of a transmembrane proton channel: an inverse relationship between stability and function. J Mol Biol. 2005;347:169–179. doi: 10.1016/j.jmb.2005.01.023. [DOI] [PubMed] [Google Scholar]
- 44.Rosenberg MR, Casarotto MG. Coexistence of two adamantane binding sites in the influenza A M2 ion channel. Proc Natl Acad Sci U S A. 2010;107:13866–13871. doi: 10.1073/pnas.1002051107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Andreas LB, Eddy MT, Pielak RM, Chou J, Griffin RG. Magic angle spinning NMR investigation of influenza A M2(18–60): support for an allosteric mechanism of inhibition. J Am Chem Soc. 2010;132:10958–10960. doi: 10.1021/ja101537p. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Pielak RM, Chou JJ. Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel. Biochem Biophys Res Commun. 2010;40:58–63. doi: 10.1016/j.bbrc.2010.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Sharma M, Yi M, Dong H, Qin H, Peterson E, Busath DD, Zhou HX, Cross TA. Insight into the mechanism of the influenza a proton channel from a structure in a lipid bilayer. Science. 2010;330:509–512. doi: 10.1126/science.1191750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Uysal S, Vasquez V, Tereshko V, Esaki K, Fellouse FA, Sidhu SS, Koide S, Perozo E, Kossiakoff A. Crystal structure of full-length KcsA in its closed conformation. Proc Natl Acad Sci U S A. 2009;106:6644–6649. doi: 10.1073/pnas.0810663106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Cortes DM, Cuello LG, Perozo E. Molecular architecture of full-length KcsA: role of cytoplasmic domains in ion permeation and activation gating. J Gen Physiol. 2001;117:165–180. doi: 10.1085/jgp.117.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kovacs FA, Cross TA. Transmembrane four-helix bundle of influenza A M2 protein channel: structural implications from helix tilt and orientation. Biophys J. 1997;73:2511–2517. doi: 10.1016/S0006-3495(97)78279-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Hu J, Asbury T, Achuthan S, Li C, Bertram R, Quine JR, Fu R, Cross TA. Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from Influenza A virus. Biophys J. 2007;92:4335–4343. doi: 10.1529/biophysj.106.090183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Wang J, Kim S, Kovacs F, Cross TA. Structure of the transmembrane region of the M2 protein H(+) channel. Protein Sci. 2001;10:2241–2250. doi: 10.1110/ps.17901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Nguyen PA, Soto CS, Polishchuk A, Caputo GA, Tatko CD, Ma C, Ohigashi Y, Pinto LH, DeGrado WF, Howard KP. pH-induced conformational change of the influenza M2 protein C-terminal domain. Biochemistry. 2008;47:9934–9936. doi: 10.1021/bi801315m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Rossman JS, Lamb RA. Autophagy, apoptosis, and the influenza virus M2 protein. Cell Host Microbe. 2009;6:299–300. doi: 10.1016/j.chom.2009.09.009. [DOI] [PubMed] [Google Scholar]
- 55.Duong-Ly KC, Nanda V, DeGrado WF, Howard KP. The conformation of the pore region of the M2 proton channel depends on lipid bilayer environment. Protein Sci. 2005;14:856–861. doi: 10.1110/ps.041185805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Luo W, Cady SD, Hong M. Immobilization of the influenza A M2 transmembrane peptide in virus envelope-mimetic lipid membranes: a solid-state NMR investigation. Biochemistry. 2009;48:6361–6368. doi: 10.1021/bi900716s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Cross TA, Sharma M, Yi M, Zhou HX. Influence of solubilizing environments on membrane protein structures. Trends Biochem Sci. 2010 doi: 10.1016/j.tibs.2010.07.005. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Schmidt N, Mishra A, Lai GH, Wong GC. Arginine-rich cell-penetrating peptides. FEBS Lett. 2010;584:1806–1813. doi: 10.1016/j.febslet.2009.11.046. [DOI] [PubMed] [Google Scholar]
- 59.Wang J, Pielak RM, McClintock MA, Chou JJ. Solution structure and functional analysis of the influenza B proton channel. Nat Struct Mol Biol. 2009;16:1267–1271. doi: 10.1038/nsmb.1707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Hirano M, Takeuchi Y, Aoki T, Yanagida T, Ide T. Rearrangements in the KcsA cytoplasmic domain underlie its gating. J Biol Chem. 2010;285:3777–3783. doi: 10.1074/jbc.M109.084368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Li C, Qin H, Gao FP, Cross TA. Solid-state NMR characterization of conformational plasticity within the transmembrane domain of the influenza A M2 proton channel. Biochim Biophys Acta. 2007;1768:3162–3170. doi: 10.1016/j.bbamem.2007.08.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Hu F, Luo W, Cady SD, Hong M. Conformational plasticity of the influenza A M2 transmembrane helix in lipid bilayers under varying pH, drug binding, and membrane thickness. Biochim Biophys Acta. 2010 doi: 10.1016/j.bbamem.2010.09.014. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Hu F, Luo W, Hong M. Mechanisms of proton conduction and gating in influenza m2 proton channels from solid-state NMR. Science. 2010;330:505–508. doi: 10.1126/science.1191714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.McDermott A. Structure and Dynamics of Membrane Proteins by Magic Angle Spinning Solid-State NMR. Annu Rev Biophys. 2009;38:385–403. doi: 10.1146/annurev.biophys.050708.133719. [DOI] [PubMed] [Google Scholar]
- 65.Leiding T, Wang J, Martinsson J, DeGrado WF, Arskold SP. Proton and cation transport activity of the M2 proton channel from influenza A virus. Proc Natl Acad Sci U S A. 2010;107:15409–15414. doi: 10.1073/pnas.1009997107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Leiding T. PhD Dissertation. Lund University; 2010. Probing Proton Translocation in Influenza A/M2 Proteoliposomes. [Google Scholar]
- 67.Cristian L, Lear JD, DeGrado WF. Use of thiol-disulfide equilibria to measure the energetics of assembly of transmembrane helices in phospholipid bilayers. Proc Natl Acad Sci U S A. 2003;100:14772–14777. doi: 10.1073/pnas.2536751100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Chakrapani S, Cordero-Morales JF, Perozo E. A quantitative description of KcsA gating II: single-channel currents. J Gen Physiol. 2007;130:479–496. doi: 10.1085/jgp.200709844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Cuello LG, Jogini V, Cortes DM, Perozo E. Structural mechanism of C-type inactivation in K(+) channels. Nature. 2010;466:203–208. doi: 10.1038/nature09153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Alam A, Jiang Y. High-resolution structure of the open NaK channel. Nat Struct Mol Biol. 2009;16:30–34. doi: 10.1038/nsmb.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Khurana E, Dal Peraro M, DeVane R, Vemparala S, DeGrado WF, Klein ML. Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus. Proc Natl Acad Sci U S A. 2009;106:1069–1074. doi: 10.1073/pnas.0811720106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Khurana E, Devane RH, Peraro MD, Klein ML. Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus. Biochim Biophys Acta. 2010 doi: 10.1016/j.bbamem.2010.03.025. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Yi M, Cross TA, Zhou HX. Conformational heterogeneity of the M2 proton channel and a structural model for channel activation. Proc Natl Acad Sci U S A. 2009;106:13311–13316. doi: 10.1073/pnas.0906553106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Yi M, Cross TA, Zhou HX. A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine. J Phys Chem B. 2008;112:7977–7979. doi: 10.1021/jp800171m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Coleman RG, Sharp KA. Finding and characterizing tunnels in macromolecules with application to ion channels and pores. Biophys J. 2009;96:632–645. doi: 10.1529/biophysj.108.135970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Nishimura K, Kim S, Zhang L, Cross TA. The closed state of a H+ channel helical bundle combining precise orientational and distance restraints from solid state NMR. Biochemistry. 2002;41:13170–13177. doi: 10.1021/bi0262799. [DOI] [PubMed] [Google Scholar]
- 77.Brannigan G, Henin J, Law R, Eckenhoff R, Klein ML. Embedded cholesterol in the nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A. 2008;105:14418–14423. doi: 10.1073/pnas.0803029105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Lee AG. How lipids affect the activities of integral membrane proteins. Biochim Biophys Acta. 2004;1666:62–87. doi: 10.1016/j.bbamem.2004.05.012. [DOI] [PubMed] [Google Scholar]
- 79.Mould JA, Li H-C, Dudlak CS, Lear JD, Pekosz A, Lamb RA, Pinto LH. Mechanism for Proton Conduction of the M2 Ion Channel of Influenza A Virus. J Biol Chem. 2000;275:8592–8599. doi: 10.1074/jbc.275.12.8592. [DOI] [PubMed] [Google Scholar]
- 80.Moffat JC, Vijayvergiya V, Gao PF, Cross TA, Woodbury DJ, Busath DD. Proton transport through influenza A virus M2 protein reconstituted in vesicles. Biophys J. 2008;94:434–445. doi: 10.1529/biophysj.107.109082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Wang C, Lamb RA, Pinto LH. Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells. Virology. 1994;205:133–140. doi: 10.1006/viro.1994.1628. [DOI] [PubMed] [Google Scholar]
- 82.Decoursey TE. Voltage-gated proton channels and other proton transfer pathways. Physiol Rev. 2003;83:475–579. doi: 10.1152/physrev.00028.2002. [DOI] [PubMed] [Google Scholar]
- 83.Wang C, Lamb RA, Pinto LH. Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys J. 1995;69:1363–1371. doi: 10.1016/S0006-3495(95)80003-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Chizhmakov IV, Ogden DC, Geraghty FM, Hayhurst A, Skinner A, Betakova T, Hay AJ. Differences in conductance of M2 proton channels of two influenza viruses at low and high pH. J Physiol. 2003;546:427–438. doi: 10.1113/jphysiol.2002.028910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Ichinohe T, Pang IK, Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol. 2010;11:404–410. doi: 10.1038/ni.1861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Furuse Y, Suzuki A, Oshitani H. Large-Scale Sequence Analysis of M Gene of Influenza A Viruses from Different Species: Mechanisms for Emergence and Spread of Amantadine Resistance. Antimicrob Agents Chemother. 2009;53:4457–4463. doi: 10.1128/AAC.00650-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis. 2007;196:249–257. doi: 10.1086/518936. [DOI] [PubMed] [Google Scholar]
- 88.Deyde V, Garten R, Sheu T, Smith C, Myrick A, Barnes J, Xu X, Shaw M, Klimov A, Gubareva L. Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006–2008. Influenza Other Respi Viruses. 2009;3:297–314. doi: 10.1111/j.1750-2659.2009.00103.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, Smit M, Macken C, Hata M, Gog J, Miller MA, et al. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol. 2007;24:1811–1820. doi: 10.1093/molbev/msm103. [DOI] [PubMed] [Google Scholar]
- 90.Furuse Y, Suzuki A, Kamigaki T, Shimizu M, Fuji N, Oshitani H. Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol. 2009;47:841–844. doi: 10.1128/JCM.01622-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Bright RA, Medina MJ, Xu XY, Perez-Oronoz G, Wallis TR, Davis XHM, Povinelli L, Cox NJ, Klimov AI. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet. 2005;366:1175–1181. doi: 10.1016/S0140-6736(05)67338-2. [DOI] [PubMed] [Google Scholar]
- 92.Betakova T, Ciampor F, Hay AJ. Influence of residue 44 on the activity of the M2 proton channel of influenza A virus. J Gen Virol. 2005;86:181–184. doi: 10.1099/vir.0.80358-0. [DOI] [PubMed] [Google Scholar]
- 93.Sansom MSP, Kerr ID, Smith GR, Son HS. The influenza A virus M2 channel: A molecular modeling and simulation study. Virology. 1997;233:163–173. doi: 10.1006/viro.1997.8578. [DOI] [PubMed] [Google Scholar]
- 94.Ayton GS, Voth GA. Multiscale simulation of transmembrane proteins. J Struct Biol. 2007;157:570–578. doi: 10.1016/j.jsb.2006.10.020. [DOI] [PubMed] [Google Scholar]
- 95.Chen H, Wu Y, Voth GA. Proton transport behavior through the influenza A M2 channel: insights from molecular simulation. Biophys J. 2007;93:3470–3479. doi: 10.1529/biophysj.107.105742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Wu YJ, Voth GA. A computational study of the closed and open states of the influenza A M2 proton channel. Biophys J. 2005;89:2402–2411. doi: 10.1529/biophysj.105.066647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Smondyrev AM, Voth GA. Molecular dynamics simulation of proton transport through the influenza A virus M2 channel. Biophys J. 2002;83:1987–1996. doi: 10.1016/S0006-3495(02)73960-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Tang Y, Zaitseva F, Lamb RA, Pinto LH. The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J Biol Chem. 2002;14:39880–39886. doi: 10.1074/jbc.M206582200. [DOI] [PubMed] [Google Scholar]
- 99.Chizhmakov IV, Geraghty FM, Ogden DC, Hayhurst A, Antoniou M, Hay AJ. Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells. J Physiol (Lond) 1996;494:329–336. doi: 10.1113/jphysiol.1996.sp021495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Pinto LH, Dieckmann GR, Gandhi CS, Papworth CG, Braman J, Shaughnessy MA, Lear JD, Lamb RA, DeGrado WF. A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci U S A. 1997;94:11301–11306. doi: 10.1073/pnas.94.21.11301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Gandhi CS, Shuck K, Lear JD, Dieckmann GR, DeGrado WF, Lamb RA, Pinto LH. Cu(II) inhibition of the proton translocation machinery of the influenza A virus M2 protein. J Biol Chem. 1999;274:5474–5482. doi: 10.1074/jbc.274.9.5474. [DOI] [PubMed] [Google Scholar]
- 102.Forrest LR, DeGrado WF, Dieckmann GR, Sansom MS. Two models of the influenza A M2 channel domain: verification by comparison. Fold Des. 1998;3:443–448. doi: 10.1016/S1359-0278(98)00061-3. [DOI] [PubMed] [Google Scholar]
- 103.Lockless SW, Zhou M, MacKinnon R. Structural and thermodynamic properties of selective ion binding in a K+ channel. PLoS Biol. 2007;5:e121. doi: 10.1371/journal.pbio.0050121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Zhou Y, MacKinnon R. The occupancy of ions in the K+ selectivity filter: charge balance and coupling of ion binding to a protein conformational change underlie high conduction rates. J Mol Biol. 2003;333:965–975. doi: 10.1016/j.jmb.2003.09.022. [DOI] [PubMed] [Google Scholar]
- 105.Zhou M, MacKinnon R. A mutant KcsA K(+) channel with altered conduction properties and selectivity filter ion distribution. J Mol Biol. 2004;338:839–846. doi: 10.1016/j.jmb.2004.03.020. [DOI] [PubMed] [Google Scholar]
- 106.Morais-Cabral JH, Zhou Y, MacKinnon R. Energetic optimization of ion conduction rate by the K+ selectivity filter. Nature. 2001;414:37–42. doi: 10.1038/35102000. [DOI] [PubMed] [Google Scholar]
- 107.Berneche S, Roux B. Energetics of ion conduction through the K+ channel. Nature. 2001;414:73–77. doi: 10.1038/35102067. [DOI] [PubMed] [Google Scholar]
- 108.Phongphanphanee S, Rungrotmongkol T, Yoshida N, Hannongbua S, Hirata F. Proton transport through the influenza A M2 channel: three-dimensional reference interaction site model study. J Am Chem Soc. 2010;132:9782–9788. doi: 10.1021/ja1027293. [DOI] [PubMed] [Google Scholar]
- 109.Carnevale V, Fiorin G, Levine BG, DeGrado WF, Klein ML. Multiple Proton Confinement in the M2 Channel from the Influenza A Virus. The Journal of Physical Chemistry C. 2010 doi: 10.1021/jp107431g. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Zhou HX. Diffusion-Influenced Transport of Ions across a Transmembrane Channel with an Internal Binding Site. J Phys Chem Lett. 2010;1:1973–1976. doi: 10.1021/jz100683t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Wu Y, Voth GA. Computational studies of proton transport through the M2 channel. FEBS Lett. 2003;552:23–27. doi: 10.1016/s0014-5793(03)00779-8. [DOI] [PubMed] [Google Scholar]
- 112.Voth GA. The computer simulation of proton transport in biomolecular systems. Front Biosci. 2003;8:s1384–1379. doi: 10.2741/1213. [DOI] [PubMed] [Google Scholar]
- 113.Headrick JM, Diken EG, Walters RS, Hammer NI, Christie RA, Cui J, Myshakin EM, Duncan MA, Johnson MA, Jordan KD. Spectral signatures of hydrated proton vibrations in water clusters. Science. 2005;308:1765–1769. doi: 10.1126/science.1113094. [DOI] [PubMed] [Google Scholar]
- 114.Waters ML. Aromatic interactions in model systems. Curr Opin Chem Biol. 2002;6:736–741. doi: 10.1016/s1367-5931(02)00359-9. [DOI] [PubMed] [Google Scholar]
- 115.Song XJ, McDermott AE. Proton transfer dynamics and N-H bond lengthening in N-H center dot center dot center dot N model systems: a solid-state NMR study. Magn Reson Chem. 2001;39:S37–S43. [Google Scholar]
- 116.Perrin CL, Nielson JB. “Strong” hydrogen bonds in chemistry and biology. Annu Rev Phys Chem. 1997;48:511–544. doi: 10.1146/annurev.physchem.48.1.511. [DOI] [PubMed] [Google Scholar]
- 117.Luo W, Hong M. Conformational changes of an ion channel detected through water-protein interactions using solid-state NMR spectroscopy. J Am Chem Soc. 2010;132:2378–2384. doi: 10.1021/ja9096219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Okada A, Miura T, Takeuchi H. Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza a virus. Biochemistry. 2001;40:6053–6060. doi: 10.1021/bi0028441. [DOI] [PubMed] [Google Scholar]
- 119.Renart ML, Triano I, Poveda JA, Encinar JA, Fernandez AM, Ferrer-Montiel AV, Gomez J, Gonzalez Ros JM. Ion binding to KcsA: implications in ion selectivity and channel gating. Biochemistry. 2010;49:9480–9487. doi: 10.1021/bi101235v. [DOI] [PubMed] [Google Scholar]
- 120.Hu J, Fu R, Cross TA. The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain. Biophys J. 2007;93:276–283. doi: 10.1529/biophysj.106.102103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Wang J, Cady SD, Balannik V, Pinto LH, DeGrado WF, Hong M. Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus. J Am Chem Soc. 2009;131:8066–8076. doi: 10.1021/ja900063s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Balannik V, Wang J, Ohigashi Y, Jing X, Magavern E, Lamb RA, Degrado WF, Pinto LH. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Biochemistry. 2009;48:11872–11882. doi: 10.1021/bi9014488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Furuse Y, Suzuki A, Kamigaki T, Oshitani H. Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol J. 2009:6. doi: 10.1186/1743-422X-6-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Qin G, Yu K, Shi T, Luo C, Li G, Zhu W, Jiang H. How does influenza virus a escape from amantadine? J Phys Chem B. 2010;114:8487–8493. doi: 10.1021/jp911588y. [DOI] [PubMed] [Google Scholar]
- 125.Eleftheratos S, Spearpoint P, Ortore G, Kolocouris A, Martinelli A, Martin S, Hay A. Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-Docking using a pore blocking model. Bioorg Med Chem Lett. 20:4182–4187. doi: 10.1016/j.bmcl.2010.05.049. [DOI] [PubMed] [Google Scholar]
- 126.Wang JF, Wei DQ, Chou KC. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus. Biochem Biophys Res Commun. 2009;388:413–417. doi: 10.1016/j.bbrc.2009.08.026. [DOI] [PubMed] [Google Scholar]
- 127.Kozakov D, Chuang GY, Beglov D, Vajda S. Where does amantadine bind to the influenza virus M2 proton channel? Trends Biochem Sci. 2010;35:471–475. doi: 10.1016/j.tibs.2010.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Chuang GY, Kozakov D, Brenke R, Beglov D, Guarnieri F, Vajda S. Binding Hot Spots and Amantadine Orientation in the Influenza A Virus M2 Proton Channel. Biophys J. 2009;97:2846–2853. doi: 10.1016/j.bpj.2009.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Laohpongspaisan C, Rungrotmongkol T, Intharathep P, Malaisree M, Decha P, Aruksakunwong O, Sompornpisut P, Hannongbua S. Why amantadine loses its function in influenza m2 mutants: MD simulations. J Chem Inf Model. 2009;49:847–852. doi: 10.1021/ci800267a. [DOI] [PubMed] [Google Scholar]
- 130.Grigoryan G, Moore DT, DeGrado WF. Design Principles Underlying Signaling and Conformational Change in Membrane Proteins. Annu Rev Biochem. 2011:80. doi: 10.1146/annurev-biochem-091008-152423. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]

